Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

In the 25 years since the first TIPS intervention has been performed, technical standards,
indications, and contraindications have been set up. The previous considerable problem of …

Portal vein thrombosis is an important cause of portal hypertension. PVT occurs in
association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or …

Background and Aims Extrahepatic portal vein occlusion (EHPVO) from portal vein
thrombosis is a rare condition associated with substantial morbidity and mortality. The …

Background Portal vein obstruction may be due to portal vein thrombosis (PVT) or its
sequale, the portal cavernoma. PVT is a common complication in liver cirrhosis, however, it …

Background & Aims We aimed to evaluate long-term outcome of patients with chronic non-
cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein …

Transjugular intrahepatic portosystemic shunt (TIPS) is used to treat complications of
cirrhosis such as variceal bleeding and refractory ascites, but it also bears the risk of liver …

Abstract Background and Aim Transjugular intrahepatic portosystemic shunt (TIPS) is the
mainstay treatment option for the complications of portal hypertension. Whether or not …

Background and Aims Cholestasis is characterized by increased total bile acid (TBA) levels,
which are regulated by farnesoid X receptor (FXR)/FGF15. Patients with primary sclerosing …